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Abstract  We developed a microfluidic device that allows isolation and genome 
amplification of individual microbial cells, thereby enabling organism-level genomic 
analysis of complex microbial ecosystems without the need for culture. This device was 
used to perform a directed survey of the human subgingival crevice and isolate bacteria 
with rod-like morphology.  Several isolated microbes had a 16S ribosomal RNA 
sequence that placed them in candidate phylum TM7, which has no cultivated or 
sequenced members.  Genome amplification from individual TM7 cells allowed us to 
sequence and assemble more than 1,000 genes, providing the first insights into the 
physiology of members of this phylum and the first genetic analysis of  any uncultivated 
minority member of a microbial community. 
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Introduction 
Earth contains enormous microbial diversity; microbes colonize a wide variety of 
environmental niches creating complex ecosystems and communities. Despite the 
marvelous progress in microbiology over the past century, we have only scratched the 
surface of this microbial world: it has been estimated that fewer than 1% of bacterial 
species have been axenically cultured, and fewer than half of the recognized bacterial 
phyla have cultivated representatives (1). This can be viewed as biology’s “dark matter” 
problem: just as astronomers have been able to infer indirectly the existence of a large 
amount of as-yet-undetected mass in the universe, microbiologists are only able to 
estimate microbial diversity by techniques such as comparative 16S ribosomal RNA gene 
analysis (2), community DNA hybridization efficiency (3), and metagenomic gene 
inventories (4). While these techniques are useful, the cell, which is the ultimate unit of 
biological organization, is lost as a distinct informational entity. 
There have been two general approaches to this problem. The first is to work on 
simple communities that contain only a few microbial species, in which case genome 
sequences can be reconstructed computationally after sequencing bulk DNA purified 
from the community (5). The second approach has been to isolate individual cells by 
fluorescence activated cell sorting (FACS), micromanipulation, or serial dilution, 
followed by genomic DNA amplification with techniques such as multiple strand 
displacement amplification (MDA) (6,7). The latter approach has been successfully used 
to perform genomic analysis of the cultivated and abundant marine bacterium 
Prochlorococcus MIT9312 (7). However, this approach remains difficult for two primary 
reasons: the confidence needed to assert the presence of single cells in microliter 
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volumes, and the meticulous reagent cleaning and sample handling required to suppress 
background amplification in microliter volume MDA (6). Those hurdles become even 
greater when complex environmental samples are used. The number of species present 
requires substantial reagent consumption and expensive post amplification screening, and 
the probability of contamination is much higher due to the presence of free DNA. Neither 
approach has been validated with a complex ecosystem. 
We designed and fabricated a microfluidic chip to address these limitations. This 
device provides the ability to perform parallel isolation of single bacteria by steering 
them to any one of 8 individually addressable chambers, followed by lysis and 
amplification of their individual genomes in 60 nanoliter volumes. By using nanoliter 
volumes, the specific template concentration is increased by three orders of magnitude, as 
previously suggested (8,9). To demonstrate the potential of this approach in microbial 
ecology, we performed a selective survey of microbes found in the human subgingival 
crevice, followed by whole genome amplification and high throughput sequencing. The 
16S ribosomal RNA gene-based phylogeny of several of these microbes placed them 
within the candidate phylum TM7, for which no cultivated or sequenced members exist 
(12), thereby providing the first genetic information about oral representatives of the 
TM7 phylum. 
 
 
Results and Discussion 
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The microfluidic strategy for microbe isolation and genome amplification (Figure 
1) was validated on Escherichia coli. More than two dozen amplifications on single E. 
coli cells were performed, with a success rate of >90%. Subsequent PCR analysis of 10 
genomic loci distributed over the E. coli chromosome showed that the amplification 
achieved excellent coverage and was able to amplify sequences with equal efficacy 
independent of their location on the genome. (Supplementary figure 5) Control 
experiments with only culture fluid in the chamber showed no significant amplification.  
We then demonstrated the ability to select, isolate and amplify the genomes of 
single bacteria from the human oral microbiota. The number of species in the human 
mouth is estimated to be about 700 (11,23). Due to the challenges of removing intact 
biofilm samples, rather than performing a comprehensive survey of this complex 
community our purpose was instead to target an unexplored phylum and a relatively rare 
subset of the oral microbiota, TM7. By selecting microbial cells with a rod-like 
morphotype, we expected to enrich for the candidate phylum TM7 (13,14). Little is 
known about the TM7 lineage. Based on comparative analyses of 16S ribosomal RNA 
genes, it is one of a number of prominent “candidate” bacterial phyla lacking any 
cultivated representatives, but comprising greater than 50 phylotypes (1). Ribosomal 
RNA gene sequences from the TM7 phylum have been found in a variety of habitats 
ranging from deep-sea hydrothermal vents to the healthy human mouth (12-14); in 
addition, sequence types within this phylum have been associated with chronic 
periodontitis in humans (13-14). Fluorescence in situ hybridizations specific for TM7 
showed that 0.7-1.9% of the subgingival microbiota belongs to the TM7 phylum (13). A 
significant subset of this phylum has a peculiar morphology, characterized by long, thick 
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filaments (up to 50 x 4 m), making these cells good candidates for a morphotype-based 
selection (12,13).  
In order to identify the amplified genomes of the isolated rod-like cells, we 
performed PCR on the 16S ribosomal RNA gene using primer sequences conserved 
across most species of the bacterial domain. Positive results for 16S rDNA PCR were 
obtained for 34 of 35 captured, single cells. After gel purification, 30 of these amplicons 
were directly sequenced; 28 of these gave unique sequences that were compared against 
the NCBI database using BLAST (24). Fig. 2 shows a phylogenetic tree based on 16S 
ribosomal RNA gene sequences of most recognized bacterial phyla, with annotations for 
isolates from the present survey. The 28 sequences from this study are associated with 5 
different bacterial phyla, with most sequences located in the phylum Fusobacteria and 
specifically related to the genus Leptotrichia.   
We identified 4 members of the phylum TM7 from the amplified cells, of which 3 
were closely related to a known oral TM7 clone (>99.6%, Genbank accession 
AY144355) (14) and a fourth clone related to a more distant lineage in the phylum 
(97.3%, AY134895) (25). To verify that the genome of a unique sequence type was 
amplified, the 16S rRNA amplicon of one TM7 sample (TM7a) was cloned, and 24 
clones were sequenced; 23 of the 24 clones had >99.5% sequence identity to the directly 
sequenced PCR product. To provide insight into the biology of the TM7 phylum and to 
investigate the ability to recover whole genome sequences from single uncultivated cells, 
we used the amplified genomic DNA from this sample for pyrosequencing and genome 
assembly. The resulting genome sequence data set was loaded into the IMG/M database 
(19) to facilitate comparative analysis. 
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The assembly of TM7a genomic sequence resulted in the generation of 3,245 
genes and gene fragments distributed across 1,825 scaffolds, totaling 2.86 MB. Genome 
size estimates based on approaches such as the Lander-Waterman equation (26) or the 
characterization of known, conserved, single-copy genes (27) rely on random sampling of 
the genome. Single cell amplification introduces a bias in read sampling such that we 
could not reliably estimate TM7 genome size. The assembly was fairly fragmented, with 
only 60% of the genes on multi-gene scaffolds. This suggested that there is multiple 
representation of some genes in the assembly, and that the actual number of sampled 
genes in TM7a is somewhat smaller. If one applies a more conservative filter and only 
includes genes from large contigs (defined as those having 3 or more genes), then one is 
left with 1,474 genes on 288 scaffolds; this is probably a better estimate of the number of 
unique sampled genes in TM7a. Approximately 43% of genes were assigned a predicted 
function based on homology to published sequences, and 44% of the genes were mapped 
to clusters of orthologous groups (COG) (Table 1). We tested the validity of the assembly 
by choosing 5 regions of the genome with an average size of 1 kb, designed PCR primers, 
and successfully amplified all 5 regions from aliquots of the amplified TM7a genomic 
DNA (Supplementary figure 6).   
Sequence similarity-based mapping showed that most of the TM7a genes are not 
closely related to genes from representatives of any known phyla. For example, 80% of 
the predicted TM7 proteins have less than <60% sequence identity to proteins from other 
sequenced organisms (Fig. 3). Using this approach, a full third (33%) of the TM7 genes 
have less than 30% protein sequence identity to genes from any known phylum. This 
result is consistent with other cases of genome sequencing in previously-uncharacterized 
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phyla. For example Rhodopirellula baltica was the first sequenced representative of the 
Planctomycetes phylum and 89% of its proteins have <60% identity to proteins from 
other known organisms; 20% have no matches with >30% identity. In contrast, a survey 
of 13 bacterial species in phyla with multiple sequenced representatives showed that on 
average only 15% of the proteins have <60% identity to proteins in other organisms, and 
3% are unassigned at the 30% cutoff (Supplementary figure 7). 
Although the majority of genes in the TM7a assembly are only distantly related to 
genes found in other organisms, there is a minority with relatively high sequence 
similarity (>60% identity) to genes found in members of the classes Bacilli, Clostridia, or 
Fusobacteria. The presence of these genes may be the result of extensive lateral transfer 
between species in the mouth, as has been postulated for other oral bacteria (16), or may 
be due to the presence of contaminating DNA in our samples – perhaps from free DNA 
that entered the microfluidic amplification reactor with the TM7 cell, either in solution or 
bound to the cell membrane. If the presence of these genes was due to contaminant DNA, 
one would expect them to cluster together by organism in the assembly. The data show 
that in many cases the opposite is true: genes with putative relationships to disparate 
organisms assemble onto the same contig.  The TM7a assembly does contain at least 
some exogenous DNA: examination of the raw sequencing reads shows that more than 40 
reads assembled into the TM7a 16S ribosomal rRNA gene sequence, while 4 reads 
assembled onto a separate small contig with the 16S rRNA gene sequence belonging to 
Leptotrichia species. Extrapolating from the ratio between these raw reads, we estimate 
that the proportion of Leptrichia contamination is less than 10%.  Since it is difficult to 
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assign a more precise estimate, one avenue of analysis is to interpret the TM7a assembly 
as a metagenome that is highly enriched for a TM7 bacterium. 
We also sequenced a second TM7 cell, TM7b, with an identical 16S r 
RNA gene sequence to TM7a, that had been isolated on a separate day on a separate chip. 
Ten Mb of sequence data were obtained and assembled into ~15,000 small contigs, none 
larger the 4 kb. This was not enough to provide a complete assembly, but represents a 
sampling of the genome. These sequence data were analyzed with whole genome Vista 
(wgVista) (21) as an independent confirmation of the TM7a genome assembly and to 
facilitate identification of bona fide TM7 genes. The results are shown in Fig. 4. In a 
global alignment, the vast majority of TM7b sequences could be mapped to contigs in 
TM7a with a sequence identity exceeding 70%. As a control experiment, we also aligned 
the TM7 genome sequences to Fusobacterium nucleatum (the only sequenced organism 
in the phylum Fusobacteria to which Leptotrichia belongs) and Chloroflexus aurantiacus 
(the sequenced organism with closest 16S rRNA gene sequence to TM7 in figure 2). 
Neither of the latter demonstrated substantial sequence identity to the TM7b sequence 
assembly. Sequencing multiple representatives of a novel phylum is therefore a useful 
approach for identifying bona fide target phylum genes in metagenomic samples 
containing exogenous DNA, which may be an unavoidable limitation associated with 
amplification of single cells removed from multi-species samples.  
Metabolic analysis of TM7 was performed by pooling sequence data from TM7a 
and TM7b, along with data from a third TM7 cell (TM7c).  TM7c assembled into 474 kB 
and 632 genes, but was not used as an independent reference since a sample handling 
error during sequencing caused commingling with genomic DNA from TM7a.  We 
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performed binning of the metagenome based on similarities between the three TM7 
samples and phylogenetic markers by selecting contigs that have phylogenetic marker 
genes on very long branches.  Based on the presence of recognizable signature genes, the 
oral TM7 cells are predicted to be capable of a range of common metabolic processes, 
such as glycolysis (3-phosphoglycerate kinase, phosphoglycerate mutase triosephosphate 
isomerase and pyruvate kinase), the TCA cycle (succinyl-CoA synthetase), nucleotide 
biosynthesis (dihydroorotate dehydrogenase, uridylate kinase, guanylate kinase, aerobic-
type ribonucleoside diphosphate reductase, thymidylate synthase) and some amino acid 
biosynthesis and salvage pathways (cysteine synthase, glycine 
hydroxymethyltransferase). We identified several genes coding for glycosyl hydrolase 
family enzymes distantly related to alpha-amylases and oligo-1,6-glucosidases, 
suggesting that oral TM7 cells may be capable of utilizing oligosaccharides as growth 
substrates. Arginine is another potential growth substrate, due to the presence of genes 
from the arginine deiminase pathway (arginine deiminase, ornithine carbamoyltransferase 
and carbamate kinase). We also identified genes for ABC transporters that are likely 
responsible for oligopeptide uptake, suggesting that TM7 cells may be capable of using 
other amino acids as well.   
It is an open question whether these bacteria have attributes associated with 
virulence, and might be capable of contributing to oral disease. We noted the presence of 
genes for type IV pilus biosynthesis, including one with similarity to that which encodes 
the Vibrio vulnificus type IV pilin (28). While type IV pili may facilitate adherence of 
bacteria to epithelial cells, and contribute to biofilm formation, in Gram-positive cells, 
type IV pili have been shown to be responsible for an unusual communal form of gliding 
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motility (29). TM7 cells from a sludge bioreactor appeared to have typical Gram-positive 
cell envelopes by electron microscopy (12). Therefore, if the TM7 are Gram positive, 
their type IV pili may be involved in gliding motility.  
We also investigated genes that might participate in cell envelope biosynthesis 
and found a gene predicted to encode a novel sortase, distantly related to those of 
Firmicutes and Actinobacteria, and a gene predicted to encode a UDP-N-acetylmuramyl 
tripeptide synthetase related to those of the bifidobacteria, suggesting a specific 
relationship of the TM7 cells to the Gram-positive lineages (Supplementary figure 8). 
Interestingly, in bifidobacteria the latter enzyme is predicted to add an atypical amino 
acid (ornithine or lysine instead of the more common diaminopimelate) to the growing 
peptidoglycan chain producing an A4alpha/beta type peptidoglycan. This peptidoglycan 
type has been implicated in chronic granulomatous inflammation (30) and may serve as a 
virulence factor for oral TM7.  
In conclusion, we have isolated single bacterial cells from a complex human 
microbial community and sequenced their DNA to provide the first genetic insights into 
the TM7 phylum. The cell selection process described here used morphology as the basis 
for selection of the targeted bacteria. It would also have been possible to achieve the 
same results from an unbiased survey of the environmental sample; this simply would 
have required processing a larger number of cells. Since the cells were isolated from a 
complex bacterial biofilm with no manipulation other than pipetting and dilution, many 
environmental microbial ecosystems should be amenable with this technique. (32)  We 
predict that as genomes from the microbial dark matter are sampled using techniques 
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such as single cell amplification, a much richer tapestry of microbial evolution will 
emerge. 
 
Materials and Methods 
Microfluidic chip fabrication: Microfluidic chips (figure 1) were fabricated as 
described previously (10) using the “push up” geometry with the following adjustments. 
The flow molds contained two layers, one for feeding lines and valves (SPR220 7 μm 
high), and one for the reaction chambers (SU8 2025, 25 μm high). The control molds 
contained two layers: one layer for hydration channels under the reaction chamber (SU8 
2015, 10μm high) and one for the control lines (SU8 2025, 25μm high). 
Sample Collection and Isolation. Samples were collected from periodontal 
pockets by scraping subgingival tooth surfaces of a healthy individual (male, 40 years) 
after 5 days without tooth brushing. These biofilm specimens were dispersed, suspended 
and washed twice in 1xPBS buffer, and re-suspended in 1xPBS 0.2% Tween® 20 before 
loading onto the chip. The chip was placed on an optical microscope and the sample was 
pumped through a sorting channel. When a single rod-shaped cell or a filament with the 
appropriate morphology (13) was visually detected in front of each processing unit, an 
isolation valve was closed and the cell was examined with a higher magnification. If the 
cell satisfied the selection criteria, the sorting valve was opened and the cell was pumped 
into the sorting chamber. Otherwise, the isolation valve was reopened and another cell 
was selected. This operation was repeated for 7 processing units of the chip; the eighth 
unit was used for a negative control having only suspension fluid inside. The chip also 
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contains an independent processor with a separate, non-addressable input that was filled 
with a mixture of lysed cells as a positive control. Every template chamber was then 
carefully checked for the number of bacterial cells and a high magnification image was 
recorded for every cell (Fig. 2). Out of 42 processing units (6 chips) used, 35 contained 
only one visible cell or filament. 
Cell Lysis and Whole Genome Amplification (WGA). Lysis, neutralization, and 
WGA were performed with the REPLI-g kit (Qiagen) using the recommended protocol 
except for on-chip WGA, for which the reaction mix was supplemented by 0.2% Tween® 
20 and one additional volume of polymerase. Once all the chambers were loaded with 
cells, an hour-long lysozyme treatment was applied using 1xPBS with 0.2% Tween® 20 
and 100 Units/l of lysozyme (Epicentre). This was performed by taking advantage of 
the gas-permeability of PDMS to dead-end fill the feeding lines with the lysis buffer (Fig. 
1C), and by opening the feeding valve to push the contents of the sorting chamber into 
the lysis chamber (Fig. 1D). Lysis and DNA denaturation reagents were allowed to 
incubate for 30 min. During this time, the feeding lines were washed first with air then 
with the neutralization buffer (Fig. 1E). After completion of the lysis, the feeding valve 
was reopened, and neutralization buffer was pushed into the unit via dead-end filling of 
the neutralization chamber (Fig. 1F). After 15-20 min, washing of the feeding line was 
repeated, this time with the WGA reaction mix (Fig. 1G). The feeding valve was 
reopened and the reaction mix was used to dead-end fill the reaction chamber. With each 
WGA reaction isolated by closed valves, the chip was placed on a hotplate set at 32°C. 
The on-chip amplification took place for 10 to 16 h after which samples were retrieved 
from the chip. The amount of amplified DNA after this step was estimated to be about 50 
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ng. A second, off-chip amplification was performed with the REPLI-g kit in order to 
obtain micrograms of DNA, the amount required for sequencing.  
16S ribosomal RNA gene amplification, cloning, and sequencing. 16S ribosomal 
RNA gene PCR was performed on amplified genomic DNAs using broad-range bacterial 
primers 8FM (5’ AGAGTTTGATCMTGGCTCAG 3’) (adapted from ref 31) and 1391R 
(5’GACGGGCGGTGTGTRCA 3’) (adapted from ref 22). These primers amplify 
approximately >90% of the full-length bacterial 16S ribosomal RNA coding sequence. 
PCR mixtures were composed of 1x PCR buffer II (Applied Biosystems, Foster City, 
CA), 1.5 mM MgCl2, 0.05% Triton X-100, 20 mM tetramethylammonium chloride, 0.1 
mM concentrations of each deoxyribonucleoside triphosphate, 0.4 M concentrations of 
each primer, 2.5 U of AmpliTaq DNA polymerase (Applied Biosystems), and 1 l of 
amplified DNA in a final volume of 50 l. PCRs included 5 min at 95°C, 35 cycles of 30 
sec at 94°C, 30 sec at 55°C and 90 sec at 72°C, followed by 8 min at 72°C. PCR 
reactions were sequenced (Geneway, Hayward, CA) directly after purification from 
agarose gel using the QIAquick Gel Extraction Kit (Qiagen, Valencia, CA), or after 
cloning using the TOPO-TA cloning kit (Invitrogen).  
Genome Sequencing and Assembly. Pyrosequencing (454 Life sciences, CT) was 
performed on randomly-amplified genomic material from three TM7 cells, named TM7a, 
TM7b and TM7c. Each sequencing run yielded between 10 and 39 MB of raw data 
composed of ~100 bp reads; the reads were assembled using the 454 Newbler
TM
 
assembler and Forge whole genome shotgun assembler (D. Platt, unpublished). An initial 
assembly treating the coverage as a classic Poisson distribution indicated that the 
coverage of these genomes was quite uneven and that some regions were not joined due 
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to either excess or very low coverage. The data were reassembled with Forge using 
“metagenomic assumptions”. In this configuration, the assembler relaxes the Poisson 
depth assumption which allows for much deeper coverage and exploration of low-
coverage, less-certain overlaps between reads. All single-read, more highly error-prone 
contigs were excluded from the assembly. Genes were predicted on contigs greater or 
equal in length to an average Sanger read (750 bp) using fgenesb as previously described 
(18), then loaded into the Integrated Microbial Genomes with Microbiomes (IMG/M) 
system (19) to facilitate comparative analysis. 
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Figure captions: 
Figure 1.  A.  Photograph of a single cell isolation and genome amplification chip 
capable of processing 9 samples in parallel. To visualize the architecture, the channels 
and chambers have been filled with blue food coloring, and the control lines to actuate 
the valves have been filled with red food coloring (scale bar 5 mm). B. Schematic 
diagram of a single amplification unit. The feed line is used to bring reagents into the 
chambers when the Vr valve is open, and to the waste when the Vw valve is open. The 
Vin valve allows deposition of a single bacterium into the sorting chamber. The lysis (3.5 
nl), neutralization (3.5 nl), and reaction chambers (50 nl) are used in sequence and are 
separated by individual valves Vl, Vn, and Vr.  Valve Vout allows recovery of the 
amplified genomic material from the chip into an individual microfuge tube. C. After a 
cell is trapped in the chamber, the feed line is filled with lysis buffer.  D.  The lysis buffer 
is used to push the cell into the lysis chamber.  E.  While the lysis buffer is mixing with 
the cell solution by diffusion, the feed line is flushed.  F.  Neutralization buffer is loaded 
into the feed line and used to push the cell lysate into the neutralization chamber.  G.  
While the neutralization reaction is mixing by diffusion, the feed line is flushed.  H.  The 
WGA reagents are loaded into the feed line and used to push the neutralized cell lysate 
into the reaction chamber.  I.  The amplification reaction proceeds in a closed system 
comprising sorting, lysis, neutralization, and reaction chambers. 
 
Figure 2. Left. Phylogenetic tree showing bacterial phyla based on 16S ribosomal RNA 
gene analysis (adapted from (1)).  Green text indicates that at least one member of the 
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phylum has been cultivated, while different shades of blue indicate the number of 
genome sequencing projects in a particular phylum that were completed or in progress as 
of May, 2006.  Red numbers and percentages indicate the results of our single cell survey 
of the human subgingival crevice, in which filamentous bacteria with rod-like 
morphotypes were isolated, lysed and their genomes amplified.  Right, optical 
micrographs of the 4 TM7 cells which were isolated in this survey.  
 
Figure 3. Phylogeny mapping of the genes in the TM7a assembly using IMG/M shows 
that the majority of TM7a genes are unlike those of any previously sequenced organism.  
Column D indicates the superkingdom: A=Archaea, B=Bacteria, E=Eukarya, V=Virus.  
“No. of Genomes” is the number of genomes available for comparison in each phylum.  
“No. of hits 30%” is the number of TM7a genes with at least 30% sequence identity to a 
member of the indicated phylum.  “Histogram 30%” is a histogram representing the 
relative proportion of TM7a genes with at least 30% identity to genes in each phylum.  
“No. of hits 60%” and “Histogram 60%” represent the same analysis, but based on genes 
with at least 60% sequence identity. 
 
Figure 4. The TM7b assembly has much higher sequence similarity to the TM7a 
assembly than to Fusobacterium nucleatum or Chloroflexi aurantiacus.  Mapping was 
performed using whole genome Vista (Ref); the horizontal axis reflects the position along 
the TM7b assembly; the vertical axis reflects the similarity of 100 bp fragments from the 
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test genome to TM7b.  Pink shading indicates >70% sequence identity.  Top: Chloroflexi 
aurantiacus, Middle: Fusobacterium nucleatum, Bottom: TM7a. 
 
Table 1. Statistics characterizing TM7a assembly and annotation, derived from IMG/M. 
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Figure 1, Marcy et al 
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  Number % of Total 
DNA, total number of bases 2,864,887 100.0% 
        DNA coding number of bases 1,160,954 40.5% 
        DNA G+C number of bases 981,862 34.3% 
                        
DNA scaffolds 1,825 100.0% 
                        
Genes total number 3,245 100.0% 
        Protein coding genes 3,160 97.4% 
        Genes with function prediction 1,389 42.8% 
        Genes without function prediction 1,771 54.6% 
        Genes assigned to enzymes 530 16.3% 
        Genes connected to KEGG pathways 400 12.3% 
        Genes not connected to KEGG pathways 2,760 85.1% 
        Genes in COGs 1,422 43.8% 
        Genes in Pfam 1,221 37.6% 
 
 
 
 
Table 1, Marcy et al 
 
 
